{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T13:06:44Z","timestamp":1766668004277,"version":"3.40.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-023-04633-0","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T12:02:31Z","timestamp":1693915351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug diluent and efficacy of methylene blue in septic shock: authors\u2019 reply"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-2840","authenticated-orcid":false,"given":"Miguel","family":"Ibarra-Estrada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Aguirre-Avalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"1","key":"4633_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M, Kattan E, Aguilera-Gonz\u00e1lez P, Sandoval-Plascencia L, Rico-Jauregui U, G\u00f3mez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27(1):110.","journal-title":"Crit Care"},{"key":"4633_CR2","unstructured":"ProvayBlue\u00ae (methylene blue) injection, 0.5%, USP\u2014Potential Medication Errors Associated with Improper Preparation. https:\/\/americanregent.com\/media\/2116\/np-pb-us-0019_hcp-letter-preparation_27feb2019.pdf. Accessed 24 Oct 2023."},{"key":"4633_CR3","unstructured":"Safety Wires\u2014Don\u2019t dilute ProvayBlue in normal Saline. ISMP Nurse Advise ERR. Volume 15, Issue 5, May 2017. https:\/\/www.ismp.org\/sites\/default\/files\/attachments\/2018-03\/NurseAdviseERR201705.pdf. Accessed 24 Oct 2023."},{"key":"4633_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0310057X0203000606","volume":"30","author":"D Memis","year":"2002","unstructured":"Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30:755\u201362.","journal-title":"Anaesth Intensive Care"},{"key":"4633_CR5","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","volume":"29","author":"MY Kirov","year":"2001","unstructured":"Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbj\u00f8rnsson B, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29:1860\u20137.","journal-title":"Crit Care Med"},{"issue":"4","key":"4633_CR6","volume":"13","author":"M Tinawi","year":"2021","unstructured":"Tinawi M. New trends in the utilization of intravenous fluids. Cureus. 2021;13(4): e14619.","journal-title":"Cureus"},{"key":"4633_CR7","unstructured":"Levophed. Highlights of prescribing information. In: accessdata.fd.gov. Revised 6\/2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/007513s038lbl.pdf. Accessed 24 Oct 2023."},{"issue":"4","key":"4633_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1600-0773.1967.tb00415.x","volume":"25","author":"J H\u00e4ggendal","year":"1967","unstructured":"H\u00e4ggendal J, Johnsson G. The stability of noradrenaline in infusion solutions. Acta Pharmacol Toxicol (Copenh). 1967;25(4):461\u20134.","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"2","key":"4633_CR9","first-page":"113","volume":"63","author":"SE Walker","year":"2010","unstructured":"Walker SE, Law S, Garland J, Fung E, Iazzetta J. Stability of norepinephrine solutions in normal saline and 5% dextrose in water. Can J Hosp Pharm. 2010;63(2):113\u20138.","journal-title":"Can J Hosp Pharm"},{"key":"4633_CR10","doi-asserted-by":"publisher","first-page":"1014276","DOI":"10.3389\/fmed.2022.1014276","volume":"9","author":"S Sari-Yavuz","year":"2022","unstructured":"Sari-Yavuz S, Heck-Swain KL, Keller M, Magunia H, Feng YS, Haeberle HA. Methylene blue dosing strategies in critically ill adults with shock-A retrospective cohort study. Front Med (Lausanne). 2022;9:1014276.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4633_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00003246-199502000-00010","volume":"23","author":"JC Preiser","year":"1995","unstructured":"Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med. 1995;23(2):259\u201364.","journal-title":"Crit Care Med"},{"issue":"8","key":"4633_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/00003246-199508000-00009","volume":"23","author":"CR Daemen-Gubbels","year":"1995","unstructured":"Daemen-Gubbels CR, Groeneveld PH, Groeneveld AB, van Kamp GJ, Bronsveld W, Thijs LG. Methylene blue increases myocardial function in septic shock. Crit Care Med. 1995;23(8):1363\u201370.","journal-title":"Crit Care Med"},{"issue":"10","key":"4633_CR13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1097\/00003246-200210000-00015","volume":"30","author":"A Donati","year":"2002","unstructured":"Donati A, Conti G, Loggi S, M\u00fcnch C, Coltrinari R, Pelaia P, et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med. 2002;30(10):2271\u20137.","journal-title":"Crit Care Med"},{"issue":"3","key":"4633_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5005\/jp-journals-10071-23376","volume":"24","author":"A Jaiswal","year":"2020","unstructured":"Jaiswal A, Kumar M, Silver E. Extended continuous infusion of methylene blue for refractory septic shock. Indian J Crit Care Med. 2020;24(3):206\u20137.","journal-title":"Indian J Crit Care Med"},{"key":"4633_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13181-013-0333-8","volume":"9","author":"PR Evora","year":"2013","unstructured":"Evora PR. Methylene blue does not have to be considered only as rescue therapy for distributive shock. J Med Toxicol. 2013;9:426.","journal-title":"J Med Toxicol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04633-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T06:03:35Z","timestamp":1700373815000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04633-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4633"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04633-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"type":"electronic","value":"1364-8535"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"25 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}